Jon Kroll Bjerregaard (Jon K Bjerregaard)

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 3

Top Topics

Combination Therapy

Klebsiella Pneumoniae

Urinary Tract Infection

Top Venues

Acta oncologica (Stockholm, Sweden)

Rigshospitalet Onkologisk Klinik

University of Southern Denmark (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Rigshospitalet Onkologisk Klinik Jun 01 2017

Denmark

MD

Education History

University of Southern Denmark Sep 01 2009 - Sep 01 2012

Denmark

PHD

Publications

Peter C Petersen, Lone N Petersen, Ivan Richter Vogelius, Jon Kroll Bjerregaard, Lene Baeksgaard
A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma. Acta oncologica (Stockholm, Sweden) 60 (7) (2021)
Christian Rønn Hansen, Morten Nielsen, Anders Smedegaard Bertelsen, Irene Hazell, Eva Holtved, Ruta Zukauskaite, Jon Kroll Bjerregaard, Carsten Brink, Uffe Bernchou
Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer. Acta oncologica (Stockholm, Sweden) 56 (11) (2017)
Tanja Cruusberg Weble, Jon Kroll Bjerregaard, Peter Kissmeyer, Mogens Vyberg, Carsten Palnaes Hansen, Niels Henrik Holländer, Christoffer Johansen
Incidence of pancreatic cancer in Denmark: 70 years of registration, 1943-2012. Acta oncologica (Stockholm, Sweden) 56 (12) (2017)